Menu ×

HEALTHCARE & PHARMACEUTICAL

High-Throughput Screening (HTS) Market Segmentation by Products & Services (Consumables, Instruments, Software, and Services); by Technology (Cell-Based Assays, Lab-on-a-Chip Technology, and Label-Free Technology); by Application (Target Identification & Validation, Primary & Secondary Screening, Toxicology Assessment, and Others); and by End-User – Global Demand Analysis & Opportunity Outlook 2020-2030

  • Text Size:

Extensive insights into the Growth of High-Throughput Screening (HTS) Market amidst COVID-19

Before we witness the stabilization of economic growth in Europe and North America, Asia Pacific is estimated to bounce back progressively with countries such as China, India, South Korea and Japan witnessing more opportunities to recover from the losses sustained during COVID-19.

Being the biggest market in Eastern Europe, Russia is estimated to take the lowest hit, offering a sigh of relief to the businesses operating in the country. Whereas, GCC is estimated to observe low investments due to the sliding prices of crude oil.

We evaluate the strategies and commitment of the Giant Players in the market towards creating products and services that customers value and rely on.

In an attempt to control and eliminate the surge of coronavirus cases and meet the demand for required medical devices along with providing efficient medical services, there is a drastic shift of investments from authoritative bodies towards the healthcare sector. Where the aftermath of this pandemic may take years to be measured, Research Nester estimates notable expansion of e-health, gaming, and media and entertainment industries till the whole situation is contained and the plan of action for the recovery process is determined. There is an estimated probability of the growth in businesses going back a year if the condition is controlled in the next 2-3 months.                                                         Request Insights

Read More

IN THE NEWS

  • June 17, 2021: Danaher Corporation announced that it would acquire the high-quality plasmid DNA, mRNA, and proteins manufacturer, Aldevron, for a cash price of around USD 9.6 Billion. The acquisition would help Danaher to expand their business portfolio in the field of genomic medicine.

Global High-Throughput Screening (HTS) Market Highlights Over 2020 - 2030

The global high-throughput screening (HTS) market is estimated to garner a revenue of USD 36227.8 Million by the end of 2030 by growing at a CAGR of 8.4% over the forecast period, i.e., 2021 – 2030. Moreover, in the year 2020, the market touched a revenue of USD 16294.7 Million. The growth of the market can be attributed to growing healthcare expenditure worldwide and the increasing focus of the government of nations to develop advanced medicines for treatment of various chronic diseases. According to the statistics by the National Institute of Health (NIH), research funding in the field of biotechnology in the United States increased from USD 5698 Million in the year 2013 to USD 7767 Million in the year 2020. Moreover, with the growing concerns for chronic diseases, there is a rising demand for drug discovery amongst the biotechnology and pharmaceutical companies. As a result, these companies have implemented open, innovative models of drug discovery by collaborating with research organizations and academic institutions. Automated high-throughput screening system can test close to 1 Million compounds per day and the ultra-high-throughput screening system can test more than 1 Million compounds per day. Owing to such high effectiveness, high-throughput screening methods and protocols are widely preferred by biotechnologists, which in turn is expected to contribute to the market growth. Moreover, the growing geriatric population and the rising health expenditure worldwide are some of the additional factors anticipated to drive the market growth.

High-Throughput Screening Market Graph

Global High-Throughput Screening (HTS) Market Regional Synopsis

Regionally, the global high-throughput screening (HTS) market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America and Middle East & Africa region. The market in North America is expected to hold the highest market share by attaining the largest market revenue of USD 15722.9 Million by the end of 2030, up from a revenue of USD 7023.0 Million in the year 2020. The growth of the market in the region can primarily be attributed to the presence of a strong healthcare infrastructure, and for the presence of numerous healthcare companies who are working day in and out to develop advanced drugs and therapies to treat different diseases. According to the statistics by the World Bank, the current health expenditure, as a share of GDP, in North America, grew from 15.629% in the year 2013 to 16.415% in the year 2018. The market in the region is segmented by country into the United States and Canada, out of which, the market in the U.S. is expected to garner the highest market share throughout the forecast period and further grow with the highest CAGR of 8.6% during the forecast period.  CLICK TO DOWNLOAD SAMPLE REPORT

On the other hand, the market in the Asia Pacific is expected to grow with the highest CAGR of 8.6% throughout the forecast period, on account of the rising demand for advanced medications, backed by the increasing prevalence of chronic diseases in the region. The Asia Pacific high-throughput screening market is segmented by country into China, India, Japan, South Korea, Vietnam, Singapore, Australia, and the Rest of Asia Pacific. Out of the market in these countries, the market in China is expected to garner the largest revenue of USD 2373.4 Million by the end of 2030, while the market in India is projected to grow with the highest CAGR of 9% during the forecast period.

The study further incorporates Y-O-Y Growth, market opportunities, demand & supply and forecast future opportunity in North America (United States, Canada, Mexico), South America, Europe (U.K., Germany, France, Italy, Spain, Hungary, BENELUX [Belgium, Netherlands, Luxembourg], NORDIC [Norway, Denmark, Sweden, Finland], Poland, Russia, Rest of Europe), Asia-Pacific (China, India, Japan, South Korea, Malaysia, Indonesia, Taiwan, Hong Kong, Australia, New Zealand, Rest of Asia-Pacific), Middle East and Africa (Israel, GCC [Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman], North Africa, South Africa, Rest of Middle East and Africa).

Growth Drivers and Challenges Impacting the Growth of the Global High-Throughput Screening (HTS) Market

Growth Drivers

  • Increasing Adoption of Open Innovative Models by Biotech & Pharmaceutical Companies
  • Growing Geriatric Population

Challenges

  • Complexities in Assay Development
  • Requirement of High Capital Investment

Global High-Throughput Screening (HTS) Market Segmentation Synopsis

The global high-throughput screening (HTS) market is segmented by products & services into consumables, instruments, software, and services. Out of these segments, the consumables segment is projected to hold the largest share of the market and further grow with the highest CAGR of 8.6% during the forecast period. The segment registered a revenue of USD 6937.73 Million in the year 2020 and is further expected to touch USD 15676.79 Million by the end of 2030. Further, on the basis of technology, the market is segmented into cell-based assays, lab-on-a-chip technology, and label-free technology, out of which, the cell-based assays segment garnered the largest revenue of USD 9468.04 Million in the year 2020, and is expected to touch USD 20832.83 Million by the end of 2030. By application, the market is segmented into target identification & validation, primary & secondary screening, toxicology assessment, and others, out of which, the target identification & validation segment is projected to garner the largest revenue of USD 16925.42 Million by the end of 2030. The global high-throughput screening market is also segmented on the basis of end-user into pharmaceutical & biotechnology companies, academic & government institutes, contract research organizations, and others. Amongst these segments, the pharmaceutical & biotechnology companies segment is expected to garner the largest revenue by the end of 2030 and also grow with the second-highest CAGR of 8.3% during the forecast period

Key Companies Dominating the Market

Our report has covered detailed company profiling comprising company overview, business strategies, key product offerings, financial performance, key performance indicators, risk analysis, recent developments, regional presence, and SWOT analysis among other notable indicators for competitive positioning. Some of the prominent industry leaders in the global high-throughput screening (HTS) market that are included in our report are Agilent Technologies, Inc., Thermo Fisher Scientific, Tecan Trading AG, Promega Corporation, Hamilton Company, BPS Bioscience, Inc., PerkinElmer Inc., Merck KGaA, Carna Biosciences, Inc., Danaher Corporation, and others.

Key Reasons to Buy Our Report

  • The report covers detailed analysis comprising market share attained by each market segment and its sub-segments.
  • It covers market dynamics including growth drivers, trends, potential opportunities, price trend analysis and challenges that impact the market growth.
  • The report includes detailed company profiles of the major players dominating the market.
  • We use effective research methodologies to calculate the market numbers and provide value-added assessment for overall growth.
  • We provide customized reports as per the clients’ requirement helping them to see possible and unexpected challenges and unforeseen opportunities in order to help them reach their goal.

FREQUENTLY ASKED QUESTIONS

Global High-Throughput Screening (HTS) Market TOC

  1. Market Definition and Research Methodology
    1. Market Definition and Segmentation
    2. Assumptions and Acronyms
    3. Research Objective
    4. Research Methodology
  2. Executive Summary
  3. Industry Value Chain Analysis
  4. Market Dynamics
    1. Drivers
    2. Challenges
    3. Trends
    4. Opportunities
  5. Regulatory & Standards Landscape
  6. Industry Risk Analysis
  7. Growth Opportunity Analysis for Business Development
  8. Impact of COVID-19 on the Global High-Throughput Screening Market
  9. Average Pricing Analysis
  10. Comparative Analysis
  11. Competitive Landscape
    1. Agilent Technologies, Inc.
    2. Thermo Fisher Scientific
    3. Tecan Trading AG
    4. Promega Corporation
    5. Hamilton Company
    6. BPS Bioscience, Inc.
    7. PerkinElmer Inc.
    8. Merck KGaA
    9. Carna Biosciences, Inc.
    10. Danaher Corporation
  12. Global High-Throughput Screening Market
    1. By Value (USD Million)
    2. Global High-Throughput Screening Market Segmentation Analysis 2020-2030
      1. By Products & Services
        1. Consumables
          1. Reagents & Assay Kits
          2. Other Accessories
        2. Instruments
          1. Liquid Handling Systems
          2. Detection Systems
          3. Others
        3. Software
        4. Services
      2. By Technology
        1. Cell-Based Assays
          1. 2D Cell Culture
          2. 3D Cell Culture
            1. Scaffold-Based Technologies
              1. Hydrogel
                1. Animal Derived Hydrogels
                  1. Matrigel
                  2. Collagen
                2. Synthetic Hydrogels
                3. Alginate/Agarose
              2. Inert Matrix
              3. Micropatterned Surface
            2. Scaffold-Free Technologies
              1. Microplate
              2. Hanging-Drop Plates
              3. Ultralow Binding Plates
              4. Others
            3. Reporter-Based Assays
            4. Perfusion Cell Culture
        2. Lab-on-a-Chip Technology
        3. Label-Free Technology
      3. By Application
        1. Target Identification and Validation
        2. Primary and Secondary Screening
        3. Toxicology Assessment
        4. Others
      4. By End-User
        1. Pharmaceuticals and Biotechnology Companies
        2. Academic and Government Institutes
        3. Contract Research Organization
        4. Others
      5. By Region
        1. North America
        2. Europe
        3. Asia-Pacific
        4. Latin-America
        5. Middle East & Africa
    3. North America High-Throughput Screening Market
      1. Market by Value (USD Million)
      2. By Products & Services
        1. Consumables
          1. Reagents & Assay Kits
          2. Other Accessories
        2. Instruments
          1. Liquid Handling Systems
          2. Detection Systems
          3. Others
        3. Software
        4. Services
      3. By Technology
        1. Cell-Based Assays
          1. 2D Cell Culture
          2. 3D Cell Culture
            1. Scaffold-Based Technologies
              1. Hydrogel
                1. Animal Derived Hydrogels
                  1. Matrigel
                  2. Collagen
                2. Synthetic Hydrogels
                3. Alginate/Agarose
              2. Inert Matrix
              3. Micropatterned Surface
            2. Scaffold-Free Technologies
              1. Microplate
              2. Hanging-Drop Plates
              3. Ultralow Binding Plates
              4. Others
            3. Reporter-Based Assays
            4. Perfusion Cell Culture
        2. Lab-on-a-Chip Technology
        3. Label-Free Technology
      4. By Application
        1. Target Identification and Validation
        2. Primary and Secondary Screening
        3. Toxicology Assessment
        4. Others
      5. By End-User
        1. Pharmaceuticals and Biotechnology Companies
        2. Academic and Government Institutes
        3. Contract Research Organization
        4. Others
      6. By Country
        1. United States
        2. Canada
    4. Europe High-Throughput Screening Market
      1. Market by Value (USD Million)
      2. By Products & Services
      3. By Technology
      4. By Application
      5. By End-User
      6. By Country
        1. UK
        2. Germany
        3. France
        4. Italy
        5. Spain
        6. Russia
        7. Netherlands
        8. Rest of Europe
    5. Asia Pacific High-Throughput Screening Market
      1. Market by Value (USD Million)
      2. By Products & Services
      3. By Technology
      4. By Application
      5. By End-User
      6. By Country
        1. China
        2. India
        3. Japan
        4. South Korea
        5. Vietnam
        6. Singapore
        7. Australia
        8. Rest of Asia Pacific
    6. Latin America High-Throughput Screening Market
      1. Market by Value (USD Million)
      2. By Products & Services
      3. By Technology
      4. By Application
      5. By End-User
      6. By Country
        1. Brazil
        2. Mexico
        3. Argentina
        4. Rest of Latin America
    7. Middle East & Africa High-Throughput Screening Market
      1. Market by Value (USD Million)
      2. By Products & Services
      3. By Technology
      4. By Application
      5. By End-User
      6. By Country
        1. GCC
        2. Israel
        3. South Africa
        4. Rest of Middle East & Africa

Related Reports


Disclaimer | Privacy Policy | Terms & Conditions

Copyright © 2021 Research Nester. All Rights Reserved